Related Experiment Video
Updated: May 5, 2026
10:20
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
7.9K
TRP channels as potential drug targets.
Ulrich Wissenbach1, Barbara A Niemeyer, Veit Flockerzi
1Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Gebäude 46, 66421 Homburg Germany.
Biology of the Cell
|April 20, 2004
Summary
Transient receptor potential (TRP) channels regulate calcium (Ca2+) entry, impacting cell growth and differentiation. Altered TRP channel expression is linked to cancer development, highlighting their role in cell proliferation and disease.
Area of Science:
- Cellular Biology
- Molecular Physiology
- Ion Channel Research
Background:
- Calcium ions (Ca2+) are essential intracellular signals regulating diverse cellular functions like fertilization, secretion, and neuronal signaling.
- Intracellular Ca2+ dynamics are implicated in cell proliferation and differentiation.
- Transient receptor potential (TRP) channels are key mediators of cation and Ca2+ influx.
Purpose of the Study:
- To summarize recent findings on the expression and function of TRP channels.
- To explore the role of TRP channels in cell growth control.
- To investigate the potential involvement of TRP channels in cancer.
Main Methods:
- Review of recent scientific literature on TRP channel expression and function.
- Analysis of studies linking TRP channels to cell proliferation and differentiation.
- Examination of research connecting TRP channel alterations to oncogenesis.
Main Results:
- TRP channels are identified as primary pathways for Ca2+ entry into cells.
- TRP channel activity influences cell proliferation and differentiation processes.
- Aberrant expression of TRP channels is associated with the development of certain cancers.
Conclusions:
- TRP channels play a significant role in regulating cellular calcium homeostasis and growth.
- Understanding TRP channel function is crucial for insights into cell growth control and cancer biology.
- Further research into TRP channels may reveal novel therapeutic targets for cancer treatment.
Related Concept Videos
01:00Enzyme-linked Receptors
64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
01:15G Protein-coupled Receptors
14.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.1K
01:26Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81